申请人:Bristol-Myers Squibb Company
公开号:EP0400661A1
公开(公告)日:1990-12-05
A series of 5-halopyrimidin-2-ylpiperazinylalkyl derivatives having useful anti-ischemic properties for treatment and prevention of dirorders resulting from brain and/or spinal cord anoxia.
一系列 5-卤代嘧啶-2-基哌嗪基烷基衍生物,具有有效的抗缺血特性,可用于治疗和预防脑和/或脊髓缺氧导致的失调。